Basolateral amygdala opioids contribute to increased high-fat intake following intra-accumbens opioid administration, but not following 24-h food deprivation

Pharmacol Biochem Behav. 2010 Dec;97(2):262-6. doi: 10.1016/j.pbb.2010.08.008. Epub 2010 Aug 27.

Abstract

Previous research has demonstrated that administration of μ-opioid receptor agonists into the nucleus accumbens increases high-fat diet consumption in sated rats and has shown a role of basolateral amygdala (BLA) activity in mediating this response. The present experiments were conducted to examine the role of BLA opioid transmission in mediating high-fat feeding driven by either intra-accumbens opioid activation or 24-h home cage food deprivation. Injection of the μ-opioid agonist, d-Ala2-NMe-Phe4-Glyol5-enkephalin (DAMGO) into the nucleus accumbens (0.25μg/0.5μl/side) increased consumption of a high-fat diet, and this effect was attenuated by pre-treatment with the opioid antagonist, naltrexone (5μg/0.25μl/side) administered into the BLA. In contrast, intra-BLA naltrexone administration had no influence on the increase in high-fat intake following 24-h food deprivation. These findings suggest that BLA opioid transmission is an important mediator of palatability-driven feeding as modeled by intra-accumbens opioid activation, while BLA opioid transmission has no significant influence on the increase in high-fat feeding driven by short-term negative-energy balance.

MeSH terms

  • Amygdala / drug effects*
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology*
  • Animals
  • Behavior, Animal / drug effects
  • Diet
  • Dietary Fats*
  • Eating / drug effects*
  • Energy Metabolism / drug effects
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / administration & dosage
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology*
  • Food Deprivation / physiology*
  • Male
  • Microinjections
  • Motor Activity / drug effects
  • Naltrexone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Nucleus Accumbens*
  • Rats
  • Rats, Sprague-Dawley
  • Synaptic Transmission / drug effects

Substances

  • Analgesics, Opioid
  • Dietary Fats
  • Narcotic Antagonists
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Naltrexone